Anika Therapeutics (NASDAQ:ANIK) reported its Q4 earnings results on Tuesday, March 8, 2022 at 04:05 PM.
Here’s what investors need to know about the announcement.
Earnings
Anika Therapeutics beat estimated earnings by 8.0%, reporting an EPS of $-0.23 versus an estimate of $-0.25.
Revenue was up $3.13 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.26 which was followed by a 3.95% increase in the share price the next day.
Here’s a look at Anika Therapeutics’s past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | -0.21 | -0.06 | -0.12 | -0.01 |
| EPS Actual | 0.05 | 0.09 | 0.06 | 0.12 |
| Revenue Estimate | 36.32M | 34.76M | 32.20M | 33.50M |
| Revenue Actual | 39.54M | 38.15M | 34.29M | 32.69M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
